Tempus AI (NASDAQ:TEM) Stock Price Down 3.4% - Time to Sell?

Shares of Tempus AI, Inc. (NASDAQ:TEM - Get Free Report) were down 3.4% on Friday . The company traded as low as $44.49 and last traded at $44.64. 128,798 shares changed hands during trading, a decline of 89% from the average daily volume of 1,122,659 shares. The stock had previously closed at $46.21.

Analyst Upgrades and Downgrades

TEM has been the subject of several analyst reports. Morgan Stanley initiated coverage on shares of Tempus AI in a report on Tuesday, July 9th. They issued an "overweight" rating and a $44.00 target price for the company. Loop Capital increased their price objective on shares of Tempus AI from $48.00 to $57.00 and gave the stock a "buy" rating in a research note on Tuesday, October 15th. Needham & Company LLC restated a "buy" rating and set a $47.00 target price on shares of Tempus AI in a research note on Wednesday, August 7th. Piper Sandler initiated coverage on shares of Tempus AI in a report on Monday, August 12th. They issued a "neutral" rating and a $40.00 target price for the company. Finally, Bank of America cut Tempus AI from a "buy" rating to a "neutral" rating and raised their price target for the company from $45.00 to $60.00 in a report on Wednesday, October 2nd. Two equities research analysts have rated the stock with a hold rating and eight have issued a buy rating to the stock. According to MarketBeat.com, Tempus AI presently has a consensus rating of "Moderate Buy" and an average target price of $48.67.

Tempus AI Trading Down 5.8 %

The company's fifty day moving average price is $52.69. The company has a debt-to-equity ratio of 4.50, a quick ratio of 3.52 and a current ratio of 3.70.

Tempus AI (NASDAQ:TEM - Get Free Report) last announced its quarterly earnings results on Tuesday, August 6th. The company reported ($6.77) earnings per share for the quarter, missing the consensus estimate of ($4.41) by ($2.36). The company had revenue of $165.97 million for the quarter, compared to the consensus estimate of $159.10 million. On average, equities research analysts forecast that Tempus AI, Inc. will post -6.51 earnings per share for the current fiscal year.

Institutional Investors Weigh In On Tempus AI

Large investors have recently added to or reduced their stakes in the stock. Davidson Kempner Capital Management LP purchased a new position in shares of Tempus AI in the 2nd quarter worth approximately $2,271,000. NEA Management Company LLC bought a new stake in Tempus AI in the second quarter worth $160,048,000. Exchange Traded Concepts LLC purchased a new position in Tempus AI during the third quarter worth $3,458,000. Sculptor Capital LP bought a new position in Tempus AI during the second quarter valued at $5,085,000. Finally, Novo Holdings A S purchased a new stake in shares of Tempus AI in the second quarter valued at $142,605,000.

Tempus AI Company Profile

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.